Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Use of Antiemetic Agents in Acute Gastroenteritis 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease
Your Article Summary
A brave new beef: The US food and drug administrations review of the safety of cloned animal products
Gender Medicine, 10/23/09
Solomon LM et al. – To meet its public mandate, the US Food and Drug Administration (FDA) collected studies on the potential health hazards of eating or drinking cloned food products. Based on an earlier National Academy of Sciences study that, on closer analysis, was not nearly as sanguine, the FDA's report found no evidence of a health risk from the public's ingestion of cloned food products. This article analyzes the risks the FDA considered, and concludes that there is a disconnect between the risks the FDA assessed in these studies and the risks that might arise from cloned food products. The FDA should consider instituting effective tracking mechanisms and other diagnostics that would permit scientists and the public to answer the question of health risks posed by cloned food products.
Related Articles
16[alpha]-Bromoepiandrosterone (HE2000) limits non-productive inflammation and stimulates immunity in lungs
Clinical and Experimental Immunology, 11/02/09
Relevance Score: 64%
Efficacy and Safety Assessment of T. Angelica Herbal Tonic(R), a Phytomedicinal Product Popularly Used in Nigeria
Evidence-based Complementary and Alternative Medicine, 10/13/09
Relevance Score: 64%
Food Safety: Human Health Consequences of Use of Antimicrobial Agents in Aquaculture
Clinical Infectious Diseases, 10/07/09
Relevance Score: 64%
Menin, a product of the MENI gene, binds to estrogen receptor to enhance its activity in breast cancer cells: possibility of a novel predictive factor for tamoxifen resistance
Breast Cancer Research and Treatment, 11/04/09
Relevance Score: 62%
Novel agent for treatment of Parkinson's disease - Lu 02-750 - enters Lundbeck's development pipeline
Lundbeck, 11/02/09
Relevance Score: 62%
Today in Family Medicine...keeping you current
Receive free subspecialty "5-minute updates" via email
Achieving the AAAs of Ambulatory Care: Aptitude, Appeal, and Appreciation
Journal of Graduate Medical Education, 11/25/09
Carotid Intima-Media Thickness: Knowledge and Application to Everyday Practice
Postgraduate Medicine, 11/25/09
Chronic Obstructive Pulmonary Disease: Role of Bacteria and Updated Guide to Antibacterial Selection in the Older Patient
Drugs & Aging, 11/25/09
Sponsor
Article Search
Sponsor


See Latest Articles


